Review
BibTex RIS Cite

INTERACTIONS BETWEEN DRUGS AND THEOPHILIN, THEOB-ROMINE, CAFFEINE CONTAINING FOODS

Year 2018, Volume: 2 Issue: 2, 82 - 96, 26.12.2018

Abstract

Drug-food interactions are frequently observed when used concomitantly. In particular, the interaction of drugs with widely consumed food containing theophylline, caffeine and theobro-mine is at the top of the list of such incidents. Theophylline, theobromine, and caffeine are often found in many foods and beverages such as tea, coffee, chocolate, cola drinks,energy drinks, icecream consumed daily have been observed to alter the pharmacokinetic and pharmacodynamic properties of drugs, resulting in interactions via various mechanisms, mainly through major drug carriers and enzyme systems which are responsible for drug absorption, metabolism, distribution and excretion. Such interactions are highly likely to result from changes in the activities of the cytochrome P-450 enzyme system and other enzymes in the intestines and liver. Although some publications refer to the interactions between drugs and foods containing theophylline, theobromine and caffeine, limited data are available. It has often been observed that medicines lead to clinically significant interactions with theophylline and caffeine-containing foods, necessitating the need of more detailed investigation. The aim of this review is to compile interactions of drugs with theophylline, theobromine and caffeine- containing foods.

References

  • [1]. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, ve ark., ‘’Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients’’. BMJ;329:15-9, (2004).
  • [2]. Kashuba A, Park JJ, Persky AM, Drug metabolism, transport, and the influence of hepatic disease. In: Burton M, Shaw LM, Schentag JJ, Evans WE, editors. Applied Pharmacokinetics. Baltimore, Md: Lippincott Williams and Wilkins;.s.121–164, (2006).
  • [3]. Goodman & Gilman. Tedavinin Farmakolojik Temelleri. Metilksantinler, s. 336, 727-730, 920. Çeviri Editörü: Süzer Ö.Nobel Tıp Kitabevleri Ltd. Şti., İstanbul, (2009)
  • [4].Survey of caffeine and other methylxanthines in energy drinks and other caffeine-containing products (updated). Food Surveillance Information Sheet, (144): 26,(No.103revised), (1998).
  • [5]. Murciano D, Auclair MH, Pariente R, Aubier M. A randomized, controlled trial of theophyl-line in patients with severe chronic obstructive pulmonary disease. N Engl J Med; 320: 1521-5, (1989).
  • [6]. Weinberger M, Hendeles L. Theophylline in asthma. N Engl J Med; 334:1380–1388, (1996).
  • [7]. Polosa R, Blackburn MR. Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol Sci;30.528–535, (2009).
  • [8].Persson CGA, Karlsson J-A, Erjefalt I: Differentiation between bronchodilation and universal adenosine antagonism among xanthine derivatives. Life Sci 30:2181, (1982).
  • [9]. Osoata GO, Yamamura S, Ito M, Vuppusetty C, Adcock IM, Barnes PJ, Ito K. Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. Biochem Biophys Res Commun;384:366– 371, (2009).
  • [10]. To Y, Ito K, Kizawa Y, Failla M, Ito M, Kusama T, Elliot M, Hogg JC, Adcock IM, Barnes PJ. Targeting phosphoinositide-3-kinase-d with theophylline reverses corticosteroid insensitivity in COPD. Am J Respir Crit Care Med;182:897–904, (2010).
  • [11]. Michalski JM, Golden G, Ikari J, Rennard SI. PDE4: a novel target in the treatment of chronic obstructive pulmonary disease. Clin Pharmacol Ther;91.134–142, (2012).
  • [12]. Henderson-Smart DJ, De Paoli AG. Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev 12: CD000140, (2010).
  • [13]. Judelson DA, Preston AG, Miller DL, Muñoz CX, Kellogg MD, Lieberman HR, Effects of theobromine and caffeine on mood and vigilance.J Clin Psychopharmacol. Aug;33(4):499-506, (2013).
  • [14]. Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtzand A, Feeley M. Effects of caffeine on human health. Food Additives and Contaminants 20(1): 1-30,(2003).
  • [15].Nurminen M, Niittynen L, Korpela R, Vapaatalo H. Coffee, caffeine and blood pressure: a critical review. European Journal of Clinical Nutrition.;53(11):831-39, (1999).
  • [16]. Patil H, Lavie C, O’Keefe J. Cuppa Joe: Friend or Foe? Efects of Chronic Cofee Consump-ton on Cardiovascular and Brain Health, Missouri Medicine.; 108(6): 339-46, (2011)
  • [17]. Geleijnse JM. Habitual coffee consumption and blood pressure: an epidemiological pers-pective. Vascular Health and Risk Management.;4(5):963-70, (2008).
  • [18].Bonita JS, Mandarano M, Shuta D, Vinson J. Coffee and Cardiovascular disease: Invitro, cellular, animal, and human studies. Pharmacological Research.; 55(3):187-98, (2007).
  • [19].Kahve Bitkisi. http://pasadankahve.com/kahve-hakkinda/kahve-bitkisi Erişim Tarihi: 06. 04. 2018
  • [20].Kırk Yıllık Hatırın Sahibi: Türk Kahvesi. https://www.beyaztarih.com/resimlerle-tarih/detay/kirk-yillik-hatrin-sahibi-turk-kahvesi Erişim Tarihi: 23. 04. 2018.
  • [21].Çakır Ercil S,Kafein: Kafein Kaynakları, Besinlerdeki Kafein Miktarları ve Kafeinin Zararları. http://www.tavsiyeediyorum.com/makale_6059.htm Erişim Tarihi: 23. 04. 2018.
  • [22].25 Most Severe Caffeine and Drug Interacti-onshttps://www.caffeineinformer.com/caffeine-drug-interactions. Erişim Tarihi: 11. 03. 2018.
  • [23].Minik Bir Çekirdekten Çıkıp Çikolataya Dönüşen Kakaonun Serotonin Dolu Yolculuğu. https://yemek.com/kakao-nedir-kakaonun-tarihi-cikolata-nasil-yapilir/#gref Erişim Tarihi: 23. 04. 2018.
  • [24].Lee KW, Kim YJ, Lee H, Lee CY. Cocoa Has More Phenolic Phytochemicals and a Higher Antioxidant Capacity than Teas and Red Wine. Journal of Agricultural and Food Chemistry.;51 (25), 7292-7295, (2003).
  • [25]. Theobromine Drug Interactionshttps://www.drugbank.ca/drugs/DB01412 Erişim Tarihi: 23. 04. 2018.
  • [26].Jayson C, Caffeine vs. Chocolate: A Mighty Methyl Group. https://scienceandfooducla.wordpress.com/2015/09/29/caffeine-vs-chocolate-a-mighty-methyl-group/ Erişim Tarihi: 23. 04. 2018.
  • [27].Matissek, R. Evaluation of xanthine derivatives in chocolate - nutritional and chemical aspects. Zeitschrift für Lebensmitteluntersuchung und -Forschung A, 205: 175-184, (1997).
  • [28].Drug-Herb Interactions: Ephedrine and Pseudoephedrine. http://www.the-cma.org.uk/articles/ephedrine-and-pseudoephedrine-3211/ Erişim Tarihi: 03. 05. 2018.
  • [29].Lowry, N, Tea and Theophylline http://helios.hampshire.edu/~nlNS/mompdfs/TeaTheoph.pdf Erişim Tarihi: 18. 05. 2018.
  • [30].Çay Bitkisinin Özelliklerihttp://rizeziraatodasi.com/cay-bitkisinin-ozellikleri/ Erişim Tarihi: 11. 06. 2018.
  • [31].Çay Bitkisinden Üretilen Çayların Kafein Miktarları http://www.bitkicaylarininfaydalari.com/cay-bitkisinden-uretilen-caylarin-kafein-miktarlari/ Erişim Tarihi: 11. 06. 2018. [32].BazinetL, Labbé DP, TremblayA,Production of green tea EGC- and EGCG-enriched fractions by a two-step extraction procedure. Separation and Purification Technology 56(1):53-56, (2007).
  • [33].Hicks MB, Hsieh YH, Bell LN, Tea preparation and its influence on methylxanthine con-centration. Research International 29(3-4):325-330.

İLAÇLAR İLE TEOFİLİN, TEOBROMİN, KAFEİN İÇEREN BESİNLER ARASINDAKİ ETKİLEŞİMLER

Year 2018, Volume: 2 Issue: 2, 82 - 96, 26.12.2018

Abstract

İlaç-besin etkileşimleri, ilaçların genellikle besinler ile birlikte alınmaları nedeniyle sıklıkla ortaya çıkar. Özellikle teofilin, kafein ve teobromin içeren ve çok yaygın olarak tüketilen besinler ile ilaçların etkileşimleri sık karşılaşılan durumların başında gelmektedir. Teofilin, teobromin ve kafein günlük olarak tüketilen çay, kahve, çikolata, kolalı içecekler, enerji içecekleri, dondurma gibi birçok yiyecek ve içeceğin, ilaçların absorbsiyonundan, metabolizmasından, dağılımından ve atılımından sorumlu çeşitli mekanizmalar aracılığı ile ilaçların farmakokinetik ve farmakodinamik özelliklerini değiştirebilirler. Bu kapsamda besinler başlıca barsakta veya karaciğerde ilaç taşıyıcıları ve enzim sistemlerinin, örneğin sitokrom P-450 veya diğer enzimlerin aktivitelerini değiştirmektedir. Birçok kaynakta ilaçlar ile teofilin, teobromin ve kafein içeren besinler arasındaki etkileşimlerden sınırlı ve kısıtlı da olsa bahsedilmektedir. Genellikle ilaçların teofilin ve kafein içeren besinler arası klinik açıdan önemli etkile-şimlere yol açtığı gözlemlenmiş ve daha detaylı inceleme gerektiği sonucuna varılmıştır. Bu makalede, ilaçlar ile teofilin, teobromin ve kafein içeren besinler arasındaki etkileşimler derlemiştir.

References

  • [1]. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, ve ark., ‘’Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients’’. BMJ;329:15-9, (2004).
  • [2]. Kashuba A, Park JJ, Persky AM, Drug metabolism, transport, and the influence of hepatic disease. In: Burton M, Shaw LM, Schentag JJ, Evans WE, editors. Applied Pharmacokinetics. Baltimore, Md: Lippincott Williams and Wilkins;.s.121–164, (2006).
  • [3]. Goodman & Gilman. Tedavinin Farmakolojik Temelleri. Metilksantinler, s. 336, 727-730, 920. Çeviri Editörü: Süzer Ö.Nobel Tıp Kitabevleri Ltd. Şti., İstanbul, (2009)
  • [4].Survey of caffeine and other methylxanthines in energy drinks and other caffeine-containing products (updated). Food Surveillance Information Sheet, (144): 26,(No.103revised), (1998).
  • [5]. Murciano D, Auclair MH, Pariente R, Aubier M. A randomized, controlled trial of theophyl-line in patients with severe chronic obstructive pulmonary disease. N Engl J Med; 320: 1521-5, (1989).
  • [6]. Weinberger M, Hendeles L. Theophylline in asthma. N Engl J Med; 334:1380–1388, (1996).
  • [7]. Polosa R, Blackburn MR. Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol Sci;30.528–535, (2009).
  • [8].Persson CGA, Karlsson J-A, Erjefalt I: Differentiation between bronchodilation and universal adenosine antagonism among xanthine derivatives. Life Sci 30:2181, (1982).
  • [9]. Osoata GO, Yamamura S, Ito M, Vuppusetty C, Adcock IM, Barnes PJ, Ito K. Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. Biochem Biophys Res Commun;384:366– 371, (2009).
  • [10]. To Y, Ito K, Kizawa Y, Failla M, Ito M, Kusama T, Elliot M, Hogg JC, Adcock IM, Barnes PJ. Targeting phosphoinositide-3-kinase-d with theophylline reverses corticosteroid insensitivity in COPD. Am J Respir Crit Care Med;182:897–904, (2010).
  • [11]. Michalski JM, Golden G, Ikari J, Rennard SI. PDE4: a novel target in the treatment of chronic obstructive pulmonary disease. Clin Pharmacol Ther;91.134–142, (2012).
  • [12]. Henderson-Smart DJ, De Paoli AG. Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev 12: CD000140, (2010).
  • [13]. Judelson DA, Preston AG, Miller DL, Muñoz CX, Kellogg MD, Lieberman HR, Effects of theobromine and caffeine on mood and vigilance.J Clin Psychopharmacol. Aug;33(4):499-506, (2013).
  • [14]. Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtzand A, Feeley M. Effects of caffeine on human health. Food Additives and Contaminants 20(1): 1-30,(2003).
  • [15].Nurminen M, Niittynen L, Korpela R, Vapaatalo H. Coffee, caffeine and blood pressure: a critical review. European Journal of Clinical Nutrition.;53(11):831-39, (1999).
  • [16]. Patil H, Lavie C, O’Keefe J. Cuppa Joe: Friend or Foe? Efects of Chronic Cofee Consump-ton on Cardiovascular and Brain Health, Missouri Medicine.; 108(6): 339-46, (2011)
  • [17]. Geleijnse JM. Habitual coffee consumption and blood pressure: an epidemiological pers-pective. Vascular Health and Risk Management.;4(5):963-70, (2008).
  • [18].Bonita JS, Mandarano M, Shuta D, Vinson J. Coffee and Cardiovascular disease: Invitro, cellular, animal, and human studies. Pharmacological Research.; 55(3):187-98, (2007).
  • [19].Kahve Bitkisi. http://pasadankahve.com/kahve-hakkinda/kahve-bitkisi Erişim Tarihi: 06. 04. 2018
  • [20].Kırk Yıllık Hatırın Sahibi: Türk Kahvesi. https://www.beyaztarih.com/resimlerle-tarih/detay/kirk-yillik-hatrin-sahibi-turk-kahvesi Erişim Tarihi: 23. 04. 2018.
  • [21].Çakır Ercil S,Kafein: Kafein Kaynakları, Besinlerdeki Kafein Miktarları ve Kafeinin Zararları. http://www.tavsiyeediyorum.com/makale_6059.htm Erişim Tarihi: 23. 04. 2018.
  • [22].25 Most Severe Caffeine and Drug Interacti-onshttps://www.caffeineinformer.com/caffeine-drug-interactions. Erişim Tarihi: 11. 03. 2018.
  • [23].Minik Bir Çekirdekten Çıkıp Çikolataya Dönüşen Kakaonun Serotonin Dolu Yolculuğu. https://yemek.com/kakao-nedir-kakaonun-tarihi-cikolata-nasil-yapilir/#gref Erişim Tarihi: 23. 04. 2018.
  • [24].Lee KW, Kim YJ, Lee H, Lee CY. Cocoa Has More Phenolic Phytochemicals and a Higher Antioxidant Capacity than Teas and Red Wine. Journal of Agricultural and Food Chemistry.;51 (25), 7292-7295, (2003).
  • [25]. Theobromine Drug Interactionshttps://www.drugbank.ca/drugs/DB01412 Erişim Tarihi: 23. 04. 2018.
  • [26].Jayson C, Caffeine vs. Chocolate: A Mighty Methyl Group. https://scienceandfooducla.wordpress.com/2015/09/29/caffeine-vs-chocolate-a-mighty-methyl-group/ Erişim Tarihi: 23. 04. 2018.
  • [27].Matissek, R. Evaluation of xanthine derivatives in chocolate - nutritional and chemical aspects. Zeitschrift für Lebensmitteluntersuchung und -Forschung A, 205: 175-184, (1997).
  • [28].Drug-Herb Interactions: Ephedrine and Pseudoephedrine. http://www.the-cma.org.uk/articles/ephedrine-and-pseudoephedrine-3211/ Erişim Tarihi: 03. 05. 2018.
  • [29].Lowry, N, Tea and Theophylline http://helios.hampshire.edu/~nlNS/mompdfs/TeaTheoph.pdf Erişim Tarihi: 18. 05. 2018.
  • [30].Çay Bitkisinin Özelliklerihttp://rizeziraatodasi.com/cay-bitkisinin-ozellikleri/ Erişim Tarihi: 11. 06. 2018.
  • [31].Çay Bitkisinden Üretilen Çayların Kafein Miktarları http://www.bitkicaylarininfaydalari.com/cay-bitkisinden-uretilen-caylarin-kafein-miktarlari/ Erişim Tarihi: 11. 06. 2018. [32].BazinetL, Labbé DP, TremblayA,Production of green tea EGC- and EGCG-enriched fractions by a two-step extraction procedure. Separation and Purification Technology 56(1):53-56, (2007).
  • [33].Hicks MB, Hsieh YH, Bell LN, Tea preparation and its influence on methylxanthine con-centration. Research International 29(3-4):325-330.
There are 32 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Gül Baktır

Emre Cemil G This is me

Publication Date December 26, 2018
Published in Issue Year 2018 Volume: 2 Issue: 2

Cite

APA Baktır, G., & G, E. C. (2018). İLAÇLAR İLE TEOFİLİN, TEOBROMİN, KAFEİN İÇEREN BESİNLER ARASINDAKİ ETKİLEŞİMLER. Lectio Scientific, 2(2), 82-96.
AMA Baktır G, G EC. İLAÇLAR İLE TEOFİLİN, TEOBROMİN, KAFEİN İÇEREN BESİNLER ARASINDAKİ ETKİLEŞİMLER. LectioSc. December 2018;2(2):82-96.
Chicago Baktır, Gül, and Emre Cemil G. “İLAÇLAR İLE TEOFİLİN, TEOBROMİN, KAFEİN İÇEREN BESİNLER ARASINDAKİ ETKİLEŞİMLER”. Lectio Scientific 2, no. 2 (December 2018): 82-96.
EndNote Baktır G, G EC (December 1, 2018) İLAÇLAR İLE TEOFİLİN, TEOBROMİN, KAFEİN İÇEREN BESİNLER ARASINDAKİ ETKİLEŞİMLER. Lectio Scientific 2 2 82–96.
IEEE G. Baktır and E. C. G, “İLAÇLAR İLE TEOFİLİN, TEOBROMİN, KAFEİN İÇEREN BESİNLER ARASINDAKİ ETKİLEŞİMLER”, LectioSc, vol. 2, no. 2, pp. 82–96, 2018.
ISNAD Baktır, Gül - G, Emre Cemil. “İLAÇLAR İLE TEOFİLİN, TEOBROMİN, KAFEİN İÇEREN BESİNLER ARASINDAKİ ETKİLEŞİMLER”. Lectio Scientific 2/2 (December 2018), 82-96.
JAMA Baktır G, G EC. İLAÇLAR İLE TEOFİLİN, TEOBROMİN, KAFEİN İÇEREN BESİNLER ARASINDAKİ ETKİLEŞİMLER. LectioSc. 2018;2:82–96.
MLA Baktır, Gül and Emre Cemil G. “İLAÇLAR İLE TEOFİLİN, TEOBROMİN, KAFEİN İÇEREN BESİNLER ARASINDAKİ ETKİLEŞİMLER”. Lectio Scientific, vol. 2, no. 2, 2018, pp. 82-96.
Vancouver Baktır G, G EC. İLAÇLAR İLE TEOFİLİN, TEOBROMİN, KAFEİN İÇEREN BESİNLER ARASINDAKİ ETKİLEŞİMLER. LectioSc. 2018;2(2):82-96.